Loading...
NYSE: DVA
DaVita Inc.
Healthcare · Medical - Care Facilities
●S&P 500 since 2008
Market Cap
$9.95B
52w High
$159.42
52w Low
$101.00
P/E
17.16
Volume
633.81K
Outstanding Shares
66.85M
Valuation Data Insufficient
The DCF model's fair value estimate is more than 3× the current stock price. This typically indicates unreliable model inputs — such as irregular cash flows or balance sheet distortions — rather than a genuine opportunity, so the valuation is not shown.
Company profile
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure.
CEOJavier J. Rodriguez
SectorHealthcare
IndustryMedical - Care Facilities
Employees76,000
IPO dateOct 31, 1995
Valuation
Forward P/E—
EV/EBITDA9.11
Enterprise value$24.07B
Stock splits
Sep 9, 20132:1
Jun 16, 20043:2
Oct 21, 19975:3
Profitability & growth
Revenue growth9.87%
Gross margin30.88%▼17.93%vs FY2024
Operating margin14.91%▼9.65%vs FY2024
ROE-114.7%▼114.84%vs FY2024
Analyst consensus
RatingHold
Target price$168.67▲13.33%
8
Buy
14
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 30, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$2.95
$2.70
Q3FY25
ActualEst.
$2.51
$3.17
Q4FY25
ActualEst.
$3.40
$3.24
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$3.38B
$3.44B
Q3FY25
ActualEst.
$3.42B
$3.43B
Q4FY25
ActualEst.
$3.62B
$3.34B
Q1FY26
Next Est.
—